TFO
RARE icon

Tarbox Family Office’s Ultragenyx Pharmaceutical RARE Stock Holding History

Tarbox Family Office’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-17
Closed -$1K – 776
2022
Q1 		$1K Hold
17
– – ﹤0.01% 1002
2021
Q4 		$1K Hold
17
– – ﹤0.01% 1047
2021
Q3 		$2K Hold
17
– – ﹤0.01% 959
2021
Q2 		$2K Hold
17
– – ﹤0.01% 968
2021
Q1 		$2K Hold
17
– – ﹤0.01% 922
2020
Q4 		$2K Hold
17
– – ﹤0.01% 881
2020
Q3 		$1K Hold
17
– – ﹤0.01% 1039
2020
Q2 		$1K Hold
17
– – ﹤0.01% 1036
2020
Q1 		$1K Buy
+17
New +$883 ﹤0.01% 961

Other funds holding RARE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return